Olema Oncology
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
780 Brannan St, San Francisco, Californi...Phone Number
(415) 651-7666Website
www.olema.comRevenue
-Stock Symbol
OLMAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Olema Oncology
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company is based in San Francisco, CA.Explore more
Olema Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Olema Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Olema Oncology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Olema Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Olema Oncology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Olema Oncology
Product Launch: Get notified when Olema Oncology launches new products
Earning: See what the market has to say on Olema Oncology recently announced quarterly report
Funding: Get notified immidiatlly once Olema Oncology has new funding data
Check if Olema Oncology has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Olema Oncology
Compare insights from companies similar to Olema Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Olema Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Olema Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Olema Oncology.
Olema Oncology financials insights
Gather financial insights about Olema Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series B
$54M
Series C
$85M
2024
Stock Offering
$250M
Olema Oncology Tech Stack
A closer look at the technologies used by Olema Oncology
See more technologies
Most Recent Scoops
Open Position
Person-Based
Events
Person-Based
Person-Based
Executive Moves, Finance, Investor Relations
New Hire
Executive Move
Executive Moves, New Hire
Olema Oncology News & Media
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that, in connection with the appointment of Jason V. O’Byrne as Chief Financial Officer effective August 11, 2026, the Company granted Mr. O’Byrne an employment inducement award consisting of stock optionsOlema Oncology to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer
SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced the appointment of Jason O’Byrne, MBA, as Chief Financial Officer.Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
SAN FRANCISCO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today reported financial and operating results for the second quarter ended June 30, 2026.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Olema Oncology
Sign Up For FreeTo access detailed company insights
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company is based in San Francisco, CA.... Read More
